Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03631784 |
|---|---|
| Brief Title: | A Trial of Pembrolizumab in Combination With Chemotherapy and Radiotherapy in Stage III NSCLC (KEYNOTE-799, MK-3475-799) (KEYNOTE-799) |
| First Submitted : | August 13, 2018 |
| First Submitted that Met QC Criteria : | August 13, 2018 |
| First Posted : | August 15, 2018 |
| Results First Submitted : | October 6, 2022 |
| Results First Submitted that Met QC Criteria : | October 6, 2022 |
| Results First Posted : | November 2, 2022 |
| Last Update Submitted that Met QC Criteria : | October 6, 2022 |
| Last Update Posted : | November 2, 2022 |